Screening of more than 12,000 Aspergillus fumigatus isolates collected from Dutch hospitals found 15% harbored triazole resistance mutations.
The higher death rate was likely driven by strained healthcare systems amid the pandemic and more patients susceptible to Candida species because of severe COVID-19, the researchers say.
More than 6.5 million fungal infections occur annually and cause 3.8 million deaths, and nations lack necessary tests and treatment.
Eighteen workers with blastomycosis were hospitalized (12%), and 1 patient died.
The outbreak in a riverside community sickened 5 people—1 fatally—and 6 dogs.
The infections were caused by Trichophyton mentagrophytes type VII (TMVII), a sexually transmitted fungus that causes ringworm.
Swiss drugmaker Basilea Pharmaceutica is receiving $29 million in BARDA funding to develop two first-in-class antifungals to treat drug-resistant fungal infections.
UK-based biopharmaceutical company F2G announced a $100 million financing round to advance late-stage development and commercialization of olorofim.
Eli Lilly says it will use OpenAI's generative AI to discover novel new antimicrobials.
Biotechnology company Elion Therapeutics announced it has closed an $81 million funding round to advance development of SF001, a novel polyene antifungal.
